🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Twenty-four Hour Movement Behaviors and Atherosclerotic Risk

Recruitingn/aAges 18 Years - 65 YearsAllSão Paulo State University
NCT07774507 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational study aims to investigate how 24-hour movement behaviors are associated with atherosclerotic risk in adults with rheumatoid arthritis. These behaviors include physical activity, sedentary behavior, and sleep. The main questions it aims to answer are: * Are 24-hour movement behaviors, both individually and in combination, associated with indicators of atherosclerotic risk in adults with RA? * Do changes in 24-hour movement behaviors over 12 months relate to changes in indicators of atherosclerotic risk? Participants will: * Wear activity monitors (accelerometers) continuously for 7 days to measure physical activity, sedentary behavior, and sleep. * Answer questionnaires about their health and lifestyle. * Undergo cardiovascular assessments, body composition measurements, physical fitness tests, and blood tests to measure lipid and inflammatory profile. * Return 12

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Medical diagnosis of rheumatoid arthritis. * Age between 18 and 65 years. * Provide written informed consent. * Independence in daily living activities defined as a Katz Index score of 5 or 6 points. Exclusion Criteria: * Acute infectious disease at the time of assessment. * Pregnancy or breastfeeding. * Cognitive impairment identified by the Mini-Mental State Examination according to established cutoff values. * History of cardiovascular disease, including coronary artery disease, cerebrovascular disease, peripheral arterial disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis, or pulmonary embolism. * Use of uncontrolled vasoactive medication. * Inability to comply with accelerometer wear requirements. * Inability to complete study questionnaires or physical assessments. * Invalid accelerometer data according to the study wear-time criteria.
💊

What it tests

  • Not listed
📍

Where

1 site
Sao Paulo State University
Presidente Prudente, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy